Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-80
SponsorBezmialem Vakif University

About this trial

Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment tools that are both practical and predictive of fall risk is therefore essential. This study aimed to investigate the relationship between fall frequency and three balance assessment tools: the Biodex Balance System (objective), the Falls Efficacy Scale-International (FES-I) (self-reported), and the Mini-Balance Evaluation Systems Test (Mini-BESTest) (functional).

Methods: Patients with PD at Hoehn and Yahr stages 1-3 will be included in the study. Fall data will be collected using a fall diary, while objective balance will be assessed with the Biodex Balance System, functional performance will be evaluated with the Mini-BESTest, and self-reported balance confidence will be measured with the FES-I.

Eligibility criteria

Qualifiers

Age between 40 and 80 years old

Receiving stable dopaminergic treatment

No other neurological disorders besides PD

A Standardized Mini-Mental State Examination (MMSE) score >24

Disqualifiers

Having mental or physical impairments severe enough to hinder communication

Clinically unstable condition within the past month

Participation in a rehabilitation program within the last six months

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40 Participants
are grouped into 1 trial group

Sponsors and collaborators